Divakar Selvaraj

Palghat, KL, India

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 28 publications

Apolipoprotein E in Alzheimer's disease: A review of APOE receptors, signalling pathways and therapeutic opportunities.

Apolipoprotein E in Alzheimer's disease: A review of APOE receptors, signalling pathways and therapeutic opportunities.

Journal: Molecular and cellular neurosciences

Published: April 07, 2026

Modulatory effect of porous silicon water-formulated catechin on gut microbiome in chronic unpredictable mild stress-induced dementia in a rat model.

Modulatory effect of porous silicon water-formulated catechin on gut microbiome in chronic unpredictable mild stress-induced dementia in a rat model.

Journal: Frontiers in pharmacology

Published: December 31, 2025

Covalent inhibitors in Parkinson's disease: Molecular targeting strategies for neuroprotective intervention.

Covalent inhibitors in Parkinson's disease: Molecular targeting strategies for neuroprotective intervention.

Journal: Molecular and cellular neurosciences

Published: April 10, 2025

Protective role of harmol against β-cell toxicity and glucose dysregulation in type 2 diabetes mellitus.

Protective role of harmol against β-cell toxicity and glucose dysregulation in type 2 diabetes mellitus.

Journal: European journal of pharmacology

Published: March 25, 2025

Mining privacy-preserving association rules using transaction hewer allocator and facile hash algorithm in multi-cloud environments.

Mining privacy-preserving association rules using transaction hewer allocator and facile hash algorithm in multi-cloud environments.

Journal: MethodsX

Published: December 04, 2024

Ligandrol Ameliorates High-Fat Diet- and Streptozotocin-Induced Type 2 Diabetes Mellitus and Prevents Pancreatic Islets Degeneration.

Ligandrol Ameliorates High-Fat Diet- and Streptozotocin-Induced Type 2 Diabetes Mellitus and Prevents Pancreatic Islets Degeneration.

Journal: Assay and drug development technologies

Published: November 06, 2024

Synthesis and evaluation of novel ethyl ferulate derivatives as potent Keap1 inhibitors to activate the Nrf2/ARE pathway in Parkinson's disease.

Synthesis and evaluation of novel ethyl ferulate derivatives as potent Keap1 inhibitors to activate the Nrf2/ARE pathway in Parkinson's disease.

Journal: Toxicology and applied pharmacology

Published: September 30, 2024

Probing the dark chemical matter against PDE4 for the management of psoriasis using in silico, in vitro and in vivo approach.

Probing the dark chemical matter against PDE4 for the management of psoriasis using in silico, in vitro and in vivo approach.

Journal: Molecular diversity

Published: September 15, 2024

Gene network analysis combined with preclinical studies to identify and elucidate the mechanism of action of novel irreversible Keap1 inhibitor for Parkinson's disease.

Gene network analysis combined with preclinical studies to identify and elucidate the mechanism of action of novel irreversible Keap1 inhibitor for Parkinson's disease.

Journal: Molecular diversity

Published: May 22, 2024

Oral delivery of solid lipid nanoparticles surface decorated with hyaluronic acid and bovine serum albumin: A novel approach to treat colon cancer through active targeting.

Oral delivery of solid lipid nanoparticles surface decorated with hyaluronic acid and bovine serum albumin: A novel approach to treat colon cancer through active targeting.

Journal: International journal of biological macromolecules

Published: May 15, 2024

Molecular insights into the potential effects of selective estrogen receptor β agonists in Alzheimer's and Parkinson's diseases.

Molecular insights into the potential effects of selective estrogen receptor β agonists in Alzheimer's and Parkinson's diseases.

Journal: Cell biochemistry and function

Published: December 20, 2023

Network-based drug repositioning of linagliptin as a potential agent for uterine fibroids targeting transforming growth factor-beta mediated fibrosis.

Network-based drug repositioning of linagliptin as a potential agent for uterine fibroids targeting transforming growth factor-beta mediated fibrosis.

Journal: Biochemical and biophysical research communications

Published: October 23, 2023

Showing 1-12 of 28

Last Updated: 09/26/2026